LESA LEWANDOWSKI: Open Payments
NPI 1306801998 · MOORESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,092 in 133 payments from 25 companies in 2025. Trend: 2023 $2,327 · 2024 $3,221 · 2025 $3,092
Food & beverage: $2,902Education: $190
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 22 | $463 |
| JAZZ PHARMACEUTICALS INC. | 16 | $379 |
| Regeneron Healthcare Solutions, Inc. | 12 | $280 |
| AstraZeneca Pharmaceuticals LP | 11 | $275 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $206 |
| GENZYME CORPORATION | 11 | $198 |
| United Therapeutics Corporation | 6 | $188 |
| Verona Pharma, Inc. | 10 | $178 |
| Axsome Therapeutics, Inc. | 4 | $122 |
| Inspire Medical Systems, Inc. | 3 | $111 |
Products named: DUPIXENT, XYWAV, NUCALA, BREZTRI, Tyvaso, Ohtuvayre, TRELEGY ELLIPTA, Sunosi.
Industry payments across NC — which companies pay providers there.
